CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors
Authors
Avinash Gupta
Bonanno
+17 more
Bos
Eliezer Shochat
Françoise Kraeber-Bodéré
Jan H.M. Schellens
Jean J.L. Tessier
Mark R. Middleton
Max E. Scheulen
Patricia Tresca
Ruediger Rueger
Steve Blotner
Suzanne Leijen
Valerie Meresse Naegelen
Van den Abbeele
Vanesa Lopez-Valverde
Veronique Dieras
Wilfried Ernst Erich Eberhardt
Zhi-Xin Xu
Publication date
Publisher
'American Association for Cancer Research (AACR)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1158%2F1078-0432.c...
Last time updated on 05/06/2019